Market Research Logo

Global Urinary Incontinence Therapeutics Market 2019-2023

Global Urinary Incontinence Therapeutics Market 2019-2023

About Urinary Incontinence

Urinary incontinence is any uncontrolled leakage of urine and this market report consists of the therapeutics used for the treatment of the diseases.

Technavio’s analysts forecast the Global Urinary Incontinence Therapeutics Market to grow at a CAGR of 3.12% during the period 2019-2023.

Covered in this report

The report covers the present scenario and the growth prospects of the urinary incontinence therapeutics market. To calculate the market size, the report considers the revenue generated from the application of urinary incontinence therapeutics across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, urinary incontinence therapeutics market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Allergan
  • Astellas Pharma
  • Merck
  • Novartis
  • Pfizer
Market driver
  • Robust pipeline for the development of drugs for urinary incontinence treatment
  • For a full, detailed list, view our report
Market challenge
  • Patent expiries of drugs
  • For a full, detailed list, view our report
Market trend
  • Shift toward novel formulations
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2023 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


PRESS RELEASE

Technavio Announces the Publication of its Research Report - Global Urinary Incontinence Therapeutics Market 2019-2023

Technavio recognizes the following companies as the key players in the global urinary incontinence therapeutics market: Allergan, Astellas Pharma, Merck, Novartis, and Pfizer.

Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the shift toward novel formulations. Many novel formulations are being developed for the treatment of urinary incontinence and they include the transdermal therapies and mechanism-of-action (MoA)-based therapies such as bete-3- adrenergic agonists and M3 specific anticholinergics.”

According to the report, one driver influencing this market is the robust pipeline for the development of drugs for urinary incontinence treatment. Most of the urinary incontinence therapeutics that are currently in Phase III stage are likely to get approved during the forecast period to augment the growth of the global urinary incontinence market. Furthermore, the increasing number of molecules being developed for urinary incontinence treatment will drive the demand for urinary incontinence therapeutics across the period of forecast.

Further, the report states that one challenge affecting this market is the patent expiries of drugs. Since generic drugs are copies of branded drugs, they can be independently developed only after the expiry of patents of the original products which may impede the growth of the market.

Companies Mentioned

Allergan

Astellas Pharma

Merck

Novartis

Pfizer

  • Executive summary
  • Scope of the report
  • Market landscape
    • Market ecosystem
      • Table Global CNS therapeutics market
      • Table Segments of global CNS therapeutics market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • Anticholinergic drugs - Market size and forecast 2018-2023
      • Table MoA of anticholinergic drugs
      • Table Anticholinergic drugs - Market size and forecast 2018-2023 ($ millions)
      • Table Anticholinergic drugs - Year-over-year growth 2019-2023 (%)
    • Others - Market size and forecast 2018-2023
      • Table Others - Market size and forecast 2018-2023 ($ millions)
      • Table Others - Year-over-year growth 2019-2023 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Americas - Market size and forecast 2018-2023
      • Table Americas - Market size and forecast 2018-2023 ($ millions)
      • Table Growth in geriatric population in various countries of Americas 2007 and 2017 (%)
      • Table Americas - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2018-2023
      • Table EMEA - Market size and forecast 2018-2023 ($ millions)
      • Table EMEA - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2018-2023
      • Table APAC - Market size and forecast 2018-2023 ($ millions)
      • Table APAC - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in APAC
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Prevalence, rate of urinary incontinence among the US residential care facility residents aged 65 and over 2010 (%)
    • Market challenges
      • Table Recent approvals of generic drugs
      • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • ALLERGAN
      • Table ALLERGAN - Vendor overview
      • Table ALLERGAN - Business segments
      • Table ALLERGAN - Organizational developments
      • Table ALLERGAN - Geographic focus
      • Table ALLERGAN - Segment focus
      • Table ALLERGAN - Key offerings
      • Table ALLERGAN - Key customers
    • Astellas Pharma
      • Table Astellas Pharma - Vendor overview
      • Table Astellas Pharma - Business segments
      • Table Astellas Pharma - Organizational developments
      • Table Astellas Pharma - Geographic focus
      • Table Astellas Pharma - Segment focus
      • Table Astellas Pharma - Key offerings
      • Table Astellas Pharma - Key customers
    • Merck
      • Table Merck - Vendor overview
      • Table Merck - Business segments
      • Table Merck - Organizational developments
      • Table Merck - Geographic focus
      • Table Merck - Segment focus
      • Table Merck - Key offerings
      • Table Merck - Key customers
    • Novartis
      • Table Novartis - Vendor overview
      • Table Novartis - Business segments
      • Table Novartis - Organizational developments
      • Table Novartis - Geographic focus
      • Table Novartis - Segment focus
      • Table Novartis - Key offerings
      • Table Novartis - Key customers
    • Pfizer
      • Table Pfizer - Vendor overview
      • Table Pfizer - Business segments
      • Table Pfizer - Organizational developments
      • Table Pfizer - Geographic focus
      • Table Pfizer - Segment focus
      • Table Pfizer - Key offerings
      • Table Pfizer - Key customers
  • Appendix
    • Research methodology
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report